Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
22
OCEA Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
117.84%
Day range:
$0.0005 - $0.0008
52-week range:
$0.0000 - $0.7600
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
201.9K
Avg. volume:
215.8K
1-year change:
-99.92%
Market cap:
$116.2K
Revenue:
--
EPS (TTM):
-$0.90
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Ocean Biomedical, Inc. has 3699900% upside to fair value with a price target of -- per share.
OCEA vs. S&P 500
-
Over the past 5 trading days, Ocean Biomedical, Inc. has underperformed the S&P 500 by -16.75% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ocean Biomedical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ocean Biomedical, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Ocean Biomedical, Inc. reported revenues of --.
Earnings Growth
-
Ocean Biomedical, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Ocean Biomedical, Inc. reported earnings per share of -$0.09.
Enterprise value:
8.7M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.14x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$16.4M | -$5.4M | -$4.2M | -$595K | -$958K | |
| EBITDA | -$16.4M | -$5.4M | -$4.2M | -$595K | -$958K | |
| Diluted EPS | -$3.42 | -$0.97 | -$0.91 | $0.48 | -$0.09 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.7M | $1.2M | $306K | $1.8M | $1.5M | |
| Total Assets | $1.7M | $108.3M | $306K | $2.9M | $1.6M | |
| Current Liabilities | $3.8M | $102.2K | $23.7M | $30.1M | $26.6M | |
| Total Liabilities | $3.8M | $3.3M | $55.1M | $78.7M | $94M | |
| Total Equity | -$2.1M | $105.1M | -$54.8M | -$75.8M | -$92.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.3M | -$7.3M | -$4.1M | -$485K | -$356K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.3M | $7.5M | $4.3M | -- | $909K | |
| Free Cash Flow | -$3.3M | -$7.3M | -$4.1M | -$485K | -$356K | |
OCEA
Sector
Market Cap
$116.2K
$27.9M
Price % of 52-Week High
0.07%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.49%
1-Year Price Total Return
-99.92%
-16.66%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0009
200-day SMA
Sell
Level
$0.0144
Bollinger Bands (100)
Sell
Level
0.0038 - 0.0038
Chaikin Money Flow
Sell
Level
-371.8K
20-day SMA
Sell
Level
$0.0013
Relative Strength Index (RSI14)
Sell
Level
43.1720
ADX Line
Buy
Level
18.5739
Williams %R
Buy
Level
-92.5926
50-day SMA
Sell
Level
$0.0017
MACD (12, 26)
Buy
Level
0.0001
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-142K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-376.7948)
Sell
CA Score
(Annual)
Level (-143.1875)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (727.6703)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria in June 2021 and is headquartered in Providence, RI.
Stock Forecast FAQ
In the current month, OCEA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OCEA average analyst price target in the past 3 months is --.
-
Where Will Ocean Biomedical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ocean Biomedical, Inc. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Ocean Biomedical, Inc.?
Analysts are divided on their view about Ocean Biomedical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ocean Biomedical, Inc. is a Sell and believe this share price will drop from its current level to --.
-
What Is Ocean Biomedical, Inc.'s Price Target?
The price target for Ocean Biomedical, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OCEA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ocean Biomedical, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OCEA?
You can purchase shares of Ocean Biomedical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ocean Biomedical, Inc. shares.
-
What Is The Ocean Biomedical, Inc. Share Price Today?
Ocean Biomedical, Inc. was last trading at $0.0000 per share. This represents the most recent stock quote for Ocean Biomedical, Inc.. Yesterday, Ocean Biomedical, Inc. closed at $0.0005 per share.
-
How To Buy Ocean Biomedical, Inc. Stock Online?
In order to purchase Ocean Biomedical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OCEA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OCEA
Sector
P/E ratio
--
23.85x
PEG ratio
--
-0.01x
P/B ratio
--
1.81x
Price / LTM sales
--
1.58x
Growth Metrics
OCEA
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.5%
Revenue (5-year growth)
--
6.5%
Earnings forecast
--
-$0.21
Profitability
OCEA
Sector
Profitability FY 2024
--
$3.6M
Return on invested capital
--
-31.87%
Return on assets
--
-28.18%
Return on equity
--
-37.63%
Earnings Date
Last Earnings Date
Aug
14
Next Earnings Date
Dec
21
Estimated Next Earnings Date
Mar
22
Balance Sheet
OCEA
Sector
Total cash
--
$26.4M
Short term investments
--
$25.7M
Total assets
$902K
$76.9M
Long term debt
--
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
